Dr. Stein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
University of Cape Town Faculty of MedicineClass of 1978
Certifications & Licensure
TN State Medical License 1994 - 2024
Clinical Trials
- Atherosclerosis in Rheumatoid Arthritis Start of enrollment: 2001 Sep 01
- Inflammation and Insulin Resistance in Rheumatoid Arthritis Start of enrollment: 2009 Apr 01
- Tissue Sodium in Autoimmune Disease Start of enrollment: 2018 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 710 citationsClinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 UpdateStuart A. Scott, Katrin Sangkuhl, Charles M. Stein, Jean-Sébastien Hulot, Jessica L. Mega
Clinical Pharmacology and Therapeutics. 2013-09-01 - 41 citationsGenetic polymorphism of (S)-mephenytoin 4'-hydroxylation in populations of African descent.H. G. Xie, Richard B. Kim, Charles M. Stein, Grant R. Wilkinson, Alastair J. J. Wood
British Journal of Clinical Pharmacology. 1999-09-01 - 135 citationsAllelic, genotypic and phenotypic distributions of S-mephenytoin 4′-hydroxylase (cyp2c19) in healthy Caucasian populations of European descent throughout the worldH. G. Xie, Charles M. Stein, Richard B. Kim, Grant R. Wilkinson, David A. Flockhart
Pharmacogenetics. 1999-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
